« Back to Record
Citation APA

Schmidt, M. L. M., Scheulen, M. E., Dittrich, C., Obrist, P., Marschner, N., Dirix, L. Y., Schmidt, M., Rüttinger, D., Schuler, M., Reinhardt, C., & Awada, A. (2010). An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer. Annals of oncology, 21(2), 275-282. doi:10.1093/annonc/mdp314


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/53563

Schmidt, M. L. M., Scheulen, M. E., Dittrich, C., Obrist, P., Marschner, N., Dirix, L. Y., Schmidt, M., Rüttinger, D., Schuler, M., Reinhardt, C., & Awada, A. (2010). An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer. Annals of oncology, 21(2), 275-282. doi:10.1093/annonc/mdp314